Cargando…
Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients...
Autores principales: | Di Stefano, Vincenzo, Tubiolo, Chiara, Gagliardo, Andrea, Presti, Rosalia Lo, Montana, Maria, Todisco, Massimiliano, Lupica, Antonino, Caimi, Gregorio, Tassorelli, Cristina, Fierro, Brigida, Brighina, Filippo, Cosentino, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688860/ https://www.ncbi.nlm.nih.gov/pubmed/36358365 http://dx.doi.org/10.3390/brainsci12111439 |
Ejemplares similares
-
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
por: Lupica, Antonino, et al.
Publicado: (2022) -
Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis
por: Iacono, Salvatore, et al.
Publicado: (2023) -
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
por: Vinciguerra, Claudia, et al.
Publicado: (2023) -
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis
por: Norata, Davide, et al.
Publicado: (2023) -
Is lack of habituation a biomarker of migraine? A critical perspective
por: Brighina, Filippo, et al.
Publicado: (2015)